Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apyx Medical (APYX) EBIT Margin (2016 - 2025)

Apyx Medical (APYX) has disclosed EBIT Margin for 15 consecutive years, with 0.3% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIT Margin rose 2173.0% year-over-year to 0.3%, compared with a TTM value of 12.11% through Dec 2025, up 2707.0%, and an annual FY2025 reading of 12.11%, up 2707.0% over the prior year.
  • EBIT Margin was 0.3% for Q4 2025 at Apyx Medical, up from 6.46% in the prior quarter.
  • Across five years, EBIT Margin topped out at 0.3% in Q4 2025 and bottomed at 64.57% in Q1 2024.
  • Average EBIT Margin over 5 years is 35.4%, with a median of 37.37% recorded in 2021.
  • The sharpest move saw EBIT Margin skyrocketed 10753bps in 2021, then plummeted -3699bps in 2022.
  • Year by year, EBIT Margin stood at 10.06% in 2021, then plummeted by -368bps to 47.05% in 2022, then increased by 16bps to 39.39% in 2023, then soared by 46bps to 21.43% in 2024, then surged by 101bps to 0.3% in 2025.
  • Business Quant data shows EBIT Margin for APYX at 0.3% in Q4 2025, 6.46% in Q3 2025, and 22.63% in Q2 2025.